Literature DB >> 15241533

Iodine-125 brachytherapy of brain stem tumors.

Jenö Julow1, Arpád Viola, Tibor Major, István Valálik, Sarolta Sági, László Mangel, Beáta R Kovács, Imre Repa, Gábor Bajzik, Takácsi N Zoltán, György Németh.   

Abstract

PURPOSE: To report on iodine-125 ((125)I) interstitial irradiation in the treatment of brain stem tumors. PATIENTS AND METHODS: Two patients with brain stem tumors were treated with CT- and image fusion-guided (125)I stereotactic brachytherapy.
RESULTS: By March 2003, the patients had been followed up for 47 and 13 months, respectively. In case 1, the tumor volume was 1.98 cm(3) on the control CT, indicating a 65.5% shrinkage as compared to a target volume of 5.73 cm3 at the time of brachytherapy. In case 2, shrinkage was more distinct. After irradiation, the cyst volume was 0.16 cm(3) on the control MRI, indicating a 97.4% shrinkage as compared to a target volume of 6.05 cm(3) at the time of brachytherapy, i. e., the metastasis had virtually disappeared.
CONCLUSION: CT- and image fusion-guided (125)I stereotactic brachytherapy can be performed during the biopsy session. The procedure can be well planned dosimetrically and is surgically precise.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15241533     DOI: 10.1007/s00066-004-1228-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  5 in total

1.  125I brachytherapy alone for recurrent or locally advanced adenoid cystic carcinoma of the oral and maxillofacial region.

Authors:  M-W Huang; L Zheng; S-M Liu; Y Shi; J Zhang; G-Y Yu; J-G Zhang
Journal:  Strahlenther Onkol       Date:  2013-04-28       Impact factor: 3.621

2.  Stereotactic iodine-125 brachytherapy for treatment of inoperable focal brainstem gliomas of WHO grades I and II: feasibility and long-term outcome.

Authors:  Maximilian I Ruge; Philipp Kickingereder; Thorsten Simon; Harald Treuer; Volker Sturm
Journal:  J Neurooncol       Date:  2012-05-12       Impact factor: 4.130

Review 3.  Iodine-125 brachytherapy for brain tumours--a review.

Authors:  Silke B Schwarz; Niklas Thon; Katharina Nikolajek; Maximilian Niyazi; Joerg-Christian Tonn; Claus Belka; Friedrich-Wilhelm Kreth
Journal:  Radiat Oncol       Date:  2012-03-06       Impact factor: 3.481

4.  Long-Term Results of stereotactic Brachytherapy (Temporary 125Iodine Seeds) for the Treatment of Low-Grade Astrocytoma (Grade II).

Authors:  Sohrab Shahzadi; Parisa Azimi; Khosrow Parsa
Journal:  Iran Red Crescent Med J       Date:  2013-01-05       Impact factor: 0.611

5.  Experimental iodine-125 seed irradiation of intracerebral brain tumors in nude mice.

Authors:  Joost J C Verhoeff; Lukas J A Stalpers; Annet W Coumou; Kees Koedooder; Cristina Lavini; Cornelis J F Van Noorden; Jaap Haveman; William P Vandertop; Wouter R van Furth
Journal:  Radiat Oncol       Date:  2007-09-26       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.